Read + Share
Amedeo Smart
Independent Medical Education
Sootome H, Fujita H, Ito K, Ochiiwa H, et al. Futibatinib Is a Novel Irreversible FGFR 1-4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors. Cancer Res 2020;80:4986-4997.PMID: 32973082
Email
LinkedIn
Facebook
Twitter
Privacy Policy